58 related articles for article (PubMed ID: 7784063)
1. Identification of the promoter of the human von Hippel-Lindau disease tumor suppressor gene.
Kuzmin I; Duh FM; Latif F; Geil L; Zbar B; Lerman MI
Oncogene; 1995 Jun; 10(11):2185-94. PubMed ID: 7784063
[TBL] [Abstract][Full Text] [Related]
2. Suppression of growth of renal carcinoma cells by the von Hippel-Lindau tumor suppressor gene.
Chen F; Kishida T; Duh FM; Renbaum P; Orcutt ML; Schmidt L; Zbar B
Cancer Res; 1995 Nov; 55(21):4804-7. PubMed ID: 7585510
[TBL] [Abstract][Full Text] [Related]
3. Cloning and characterization of a mouse gene with homology to the human von Hippel-Lindau disease tumor suppressor gene: implications for the potential organization of the human von Hippel-Lindau disease gene.
Gao J; Naglich JG; Laidlaw J; Whaley JM; Seizinger BR; Kley N
Cancer Res; 1995 Feb; 55(4):743-7. PubMed ID: 7850784
[TBL] [Abstract][Full Text] [Related]
4. Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function.
Kley N; Whaley J; Seizinger BR
Glia; 1995 Nov; 15(3):297-307. PubMed ID: 8586465
[TBL] [Abstract][Full Text] [Related]
5. Mutations of the VHL tumour suppressor gene in renal carcinoma.
Gnarra JR; Tory K; Weng Y; Schmidt L; Wei MH; Li H; Latif F; Liu S; Chen F; Duh FM
Nat Genet; 1994 May; 7(1):85-90. PubMed ID: 7915601
[TBL] [Abstract][Full Text] [Related]
6. Sequence of the 5'-flanking region and promoter activity of the human mucin gene MUC5B in different phenotypes of colon cancer cells.
Van Seuningen I; Perrais M; Pigny P; Porchet N; Aubert JP
Biochem J; 2000 Jun; 348 Pt 3(Pt 3):675-86. PubMed ID: 10840001
[TBL] [Abstract][Full Text] [Related]
7. Expression and regulation of the meprin beta gene in human cancer cells.
Matters GL; Bond JS
Mol Carcinog; 1999 Jul; 25(3):169-78. PubMed ID: 10411143
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
9. Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas.
Kanno H; Kondo K; Ito S; Yamamoto I; Fujii S; Torigoe S; Sakai N; Hosaka M; Shuin T; Yao M
Cancer Res; 1994 Sep; 54(18):4845-7. PubMed ID: 8069849
[TBL] [Abstract][Full Text] [Related]
10. Protein interactions at Sp1-like sites in the TGF alpha promoter as visualized by in vivo genomic footprinting.
Chen X; Wright KL; Berkowitz EA; Azizkhan JC; Ting JP; Lee DC
Oncogene; 1994 Nov; 9(11):3179-87. PubMed ID: 7936640
[TBL] [Abstract][Full Text] [Related]
11. Genetic and functional analysis of the von Hippel-Lindau (VHL) tumour suppressor gene promoter.
Zatyka M; Morrissey C; Kuzmin I; Lerman MI; Latif F; Richards FM; Maher ER
J Med Genet; 2002 Jul; 39(7):463-72. PubMed ID: 12114475
[TBL] [Abstract][Full Text] [Related]
12. [Von Hippel-Lindau disease and central nervous system hemangioblastoma. Progress in genetics and clinical management].
Richard S; Martin S; David P; Decq P
Neurochirurgie; 1998 Nov; 44(4):258-66. PubMed ID: 9864697
[TBL] [Abstract][Full Text] [Related]
13. Hepatic vascular tumors, angiectasis in multiple organs, and impaired spermatogenesis in mice with conditional inactivation of the VHL gene.
Ma W; Tessarollo L; Hong SB; Baba M; Southon E; Back TC; Spence S; Lobe CG; Sharma N; Maher GW; Pack S; Vortmeyer AO; Guo C; Zbar B; Schmidt LS
Cancer Res; 2003 Sep; 63(17):5320-8. PubMed ID: 14500363
[TBL] [Abstract][Full Text] [Related]
14. [Porcine VHL gene cloning and construction of VHL knockdown cloned embryos].
Jin H; Wang J; Wang F; Ma J; Mu Y; Liu Z
Sheng Wu Gong Cheng Xue Bao; 2013 Jun; 29(6):716-25. PubMed ID: 24063232
[TBL] [Abstract][Full Text] [Related]
15. The von Hippel-Lindau (VHL) tumor-suppressor gene is down-regulated by selenium deficiency in Caco-2 cells and rat colon mucosa.
Uthus E; Begaye A; Ross S; Zeng H
Biol Trace Elem Res; 2011 Aug; 142(2):223-31. PubMed ID: 20632125
[TBL] [Abstract][Full Text] [Related]
16. A PCR generated AccI RFLP in the 3' untranslated region of the von Hippel-Lindau disease (VHL) tumour suppressor gene.
Payne SJ; Richards FM; Maher ER
Hum Mol Genet; 1994 Feb; 3(2):390. PubMed ID: 7911705
[No Abstract] [Full Text] [Related]
17. Old protein, new function: VHL tumor suppressor protein inhibits transcription.
Nelson NJ
J Natl Cancer Inst; 1995 Oct; 87(19):1432-3. PubMed ID: 7674328
[No Abstract] [Full Text] [Related]
18. Identification and characterization of the human NOL7 gene promoter.
Mankame TP; Zhou G; Lingen MW
Gene; 2010 May; 456(1-2):36-44. PubMed ID: 20206243
[TBL] [Abstract][Full Text] [Related]
19. RalBP1 and p19-VHL play an oncogenic role, and p30-VHL plays a tumor suppressor role during the blebbishield emergency program.
Jinesh GG; Kamat AM
Cell Death Discov; 2017; 3():17023. PubMed ID: 28580172
[TBL] [Abstract][Full Text] [Related]
20. Identification of the von Hippel-Lindau disease tumor suppressor gene.
Latif F; Tory K; Gnarra J; Yao M; Duh FM; Orcutt ML; Stackhouse T; Kuzmin I; Modi W; Geil L
Science; 1993 May; 260(5112):1317-20. PubMed ID: 8493574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
